Published in BMJ Case Rep on December 11, 2013
Stent implantation for coarctation of the aorta in children <30 kg. JACC Cardiovasc Interv (2009) 1.71
Comparison of surgical and interventional therapy of native and recurrent aortic coarctation regarding different age groups during childhood. Eur J Cardiothorac Surg (2010) 1.64
Initial and six-year results of stent implantation for aortic coarctation in children. Am J Cardiol (2012) 1.57
Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur Heart J (2005) 1.36
The role of stents in the treatment of congenital heart disease: Current status and future perspectives. Ann Pediatr Cardiol (2009) 1.29
A premounted stent that can be implanted in infants and re-dilated to 20 mm: introducing the Edwards Valeo Lifestent. Catheter Cardiovasc Interv (2009) 1.13
Coarctation of the Aorta Stent Trial (COAST): study design and rationale. Am Heart J (2012) 1.02
Balloon expandable stents for coarctation of the aorta: review of current status and technical considerations. Images Paediatr Cardiol (2003) 0.88
International staging system for multiple myeloma. J Clin Oncol (2005) 11.29
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Aspirin for everyone older than 50? For. BMJ (2005) 3.02
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial. Lancet (2007) 3.01
Antimyeloma activity of heat shock protein-90 inhibition. Blood (2005) 2.24
Aspirin, salicylates, and cancer. Lancet (2009) 2.17
Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol (2011) 2.14
Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood (2003) 2.11
Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002--Medical Research Council Adult Leukaemia Working Party. J Clin Oncol (2005) 1.97
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J (2003) 1.81
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood (2011) 1.75
Effects of bone-targeted agents on cancer progression and mortality. J Natl Cancer Inst (2012) 1.69
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica (2014) 1.57
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children. Blood (2008) 1.56
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol (2014) 1.52
Treatment of relapsed and refractory multiple myeloma in the era of novel agents. Cancer Treat Rev (2010) 1.48
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell Int (2005) 1.46
Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival. BMC Med (2008) 1.40
Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype. Leuk Lymphoma (2008) 1.39
IMWG consensus on maintenance therapy in multiple myeloma. Blood (2012) 1.29
Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol (2006) 1.23
International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol (2013) 1.19
A national DNA bank in The Gambia, West Africa, and genomic research in developing countries. Nat Genet (2004) 1.13
Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod (2008) 1.13
Current multiple myeloma treatment strategies with novel agents: a European perspective. Oncologist (2010) 1.04
Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. J Nutr (2010) 1.04
More patent protection for medicines with a new purpose. Nature (2010) 1.02
Birth season and environmental influences on blood leucocyte and lymphocyte subpopulations in rural Gambian infants. BMC Immunol (2008) 1.01
Genes with a spike expression are clustered in chromosome (sub)bands and spike (sub)bands have a powerful prognostic value in patients with multiple myeloma. Haematologica (2011) 1.01
Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer (2003) 1.01
Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv (2009) 0.96
Monsanto Technology LLC v. Cargill: a matter of construction. Nat Biotechnol (2008) 0.95
Detection of intraepithelial and stromal Langerin and CCR5 positive cells in the human endometrium: potential targets for HIV infection. PLoS One (2011) 0.95
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia. J Clin Oncol (2010) 0.93
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma. Haematologica (2007) 0.92
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma. Leuk Lymphoma (2010) 0.91
High-dose cyclophosphamide with stem cell rescue for severe rheumatoid arthritis: short-term efficacy correlates with reduction of macroscopic and histologic synovitis. Arthritis Rheum (2002) 0.90
Risk factors for acute shunt blockage in children after modified Blalock-Taussig shunt operations. Heart Vessels (2010) 0.90
A randomised trial of a remote home support programme for infants with major congenital heart disease. Heart (2012) 0.89
Efficacy and outcome of autologous transplantation in rare myelomas. Haematologica (2010) 0.89
CLLU1 expression has prognostic value in chronic lymphocytic leukemia after first-line therapy in younger patients and in those with mutated IGHV genes. Haematologica (2012) 0.87
Lenalidomide: a new therapy for multiple myeloma. Cancer Treat Rev (2008) 0.86
Multiple autophosphorylations significantly enhance the endoribonuclease activity of human inositol requiring enzyme 1α. BMC Biochem (2014) 0.85
Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood (2002) 0.83
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy. Leuk Lymphoma (2012) 0.82
Longer-term outcome of perventricular device closure of muscular ventricular septal defects in children. Catheter Cardiovasc Interv (2015) 0.82
Interactions of the auxilin-1 PTEN-like domain with model membranes result in nanoclustering of phosphatidyl inositol phosphates. Biophys J (2013) 0.81
Long-term effects of perinatal nutrition on T lymphocyte kinetics in young Gambian men. Am J Clin Nutr (2007) 0.81
Sympathetic ophthalmia secondary to cyclodiode laser in a 10-year-old boy. J AAPOS (2009) 0.81
Expression of prostaglandin E synthases in periodontitis immunolocalization and cellular regulation. Am J Pathol (2011) 0.80
Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue. Histochem Cell Biol (2005) 0.80
Thymic stromal lymphopoietin is present in human breast milk. Pediatr Allergy Immunol (2010) 0.79
Updates to the guidelines for the diagnosis and management of multiple myeloma. Br J Haematol (2014) 0.79
Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. Br J Haematol (2002) 0.79
Thymic function and T cell parameters in a natural human experimental model of seasonal infectious diseases and nutritional burden. J Biomed Sci (2011) 0.78
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome. BMC Gastroenterol (2010) 0.78
Patent foramen ovale closure with the Gore septal occluder: initial UK experience. Catheter Cardiovasc Interv (2013) 0.77
Innate and adaptive immune pathways to tolerance. Nestle Nutr Workshop Ser Pediatr Program (2009) 0.77
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations. Br J Haematol (2011) 0.77
What next for low dose aspirin? J Epidemiol Community Health (2005) 0.76
Adjusting for patient crossover in clinical trials using external data: a case study of lenalidomide for advanced multiple myeloma. Value Health (2011) 0.76
Long-term clinical experience with Amplatzer Ductal Occluder II for closure of the persistent arterial duct in children. Catheter Cardiovasc Interv (2014) 0.76
The impact of cell culture equipment on energy loss. Lasers Med Sci (2013) 0.75
Antibiotics and allergic disorders in childhood. Open Nurs J (2008) 0.75
Aspirin for all over 50 revisited. Heart (2008) 0.75
On the limitations of health impact assessment. Public Health (2009) 0.75
Could vitamin S (salicylate) protect against childhood cancer? Med Hypotheses (2005) 0.75
Aspirin resistance: What is the risk of cardiovascular morbidity? BMJ (2008) 0.75
Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre. Catheter Cardiovasc Interv (2009) 0.75
The public health potential of aspirin. Pharmacol Toxicol (2002) 0.75
Vascular hemostasis bandage compared to standard manual compression after cardiac catheterization in children. Catheter Cardiovasc Interv (2011) 0.75
Highlighting the importance of "popular epidemiology". J Epidemiol Community Health (2005) 0.75
Super-resolution reconstruction based on incoherent optical aperture synthesis. Opt Lett (2013) 0.75
High dose immunosuppressive therapy and stem cell transplantation in autoimmune and inflammatory diseases. Int Immunopharmacol (2002) 0.75
Cancer-Selective Targeting of the NF-κB Survival Pathway with GADD45β/MKK7 Inhibitors. Cancer Cell (2014) 0.75
Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy. Hematology (2007) 0.75
2020 vision for Welsh 'public health'? Proposing 'public sector' footprints. Perspect Public Health (2016) 0.75
Designing and implementing healthy ageing policies. Perspect Public Health (2012) 0.75
'Healthy ageing' agenda. Perspect Public Health (2012) 0.75
My health: whose responsibility? Low-dose aspirin and older people. Expert Rev Cardiovasc Ther (2006) 0.75
'Salicylic acid deficiency' has important public health implications. Eur J Public Health (2003) 0.75
Life saving early and immediate aspirin: too little too late. Postgrad Med J (2008) 0.75
Reflective practice and self-awareness. Perspect Public Health (2009) 0.75
Retrieving a large embolised atrial septal occluder - hooked… and landed. Kardiol Pol (2017) 0.75